0001192482-18-000047.txt : 20180122
0001192482-18-000047.hdr.sgml : 20180122
20180122170017
ACCESSION NUMBER: 0001192482-18-000047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180118
FILED AS OF DATE: 20180122
DATE AS OF CHANGE: 20180122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celano Michael
CENTRAL INDEX KEY: 0001377582
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 18540391
MAIL ADDRESS:
STREET 1: 220 EAST FIRST STREET
CITY: BETHLEHEM
STATE: PA
ZIP: 18015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-01-18
0001588972
Recro Pharma, Inc.
REPH
0001377582
Celano Michael
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
0
1
0
0
Chief Operating Officer
Common Stock
2018-01-18
4
M
0
6400
A
30495
D
Common Stock
2018-01-18
4
F
0
2020
8.89
D
28475
D
Restricted Stock Units
2018-01-18
4
M
0
6400
0
D
Common Stock
6400
19200
D
Restricted stock units convert into common stock on a one-for-one basis.
On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
/s/ Ryan D. Lake, Attorney-in-fact
2018-01-22